Home Page ::: Current Drug Targets

ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)


Volume 16, 14 Issues, 2015


Download PDF Flyer




Current Drug Targets

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 77th of 254 in

    Pharmacology & Pharmacy


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:

Francis J. Castellino


Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.021
5 - Year: 3.260


Endorsement(s)

"In view of the growing volume of literature, the role of high quality review journals has become increasingly important. Current Drug Targets is an important journal in the field of medicinal chemistry and drug design, which is strongly recommended to the scientific community."

Jean-Marie Lehn
Nobel Laureate

Forthcoming Special Issue(s)

New Therapies, Markers and Therapeutic Targets in Hcv Chronic Infection, and Hcv Extrahepatic Manifestations


Guest Editor(s): Alessandro Antonelli, Mauro Pistello
Tentative Publication Date: December, 2015
Submit Abstract via Email Download Description
Published Special Issue(s)

By-Products As Scaffolds For Drug Delivery Systems: Design, Targeting Approaches, And Sustainability


Guest Editor(s): Luciano P Silva, Graziella A Joanitti
Download Description
Authors' Comments
We would like to express our gratitude to Bentham Science Publishers for the wonderful experience while working with the journal on this mini-thematic issue. There are several reasons for this enthusiasm.
We are grateful to the Editor-in-Chief, Dr Francis J. Castellino, for contacting us and offering us the chance to publish in Current Drug Targets, and accepting our proposal for a mini-thematic issue. It was a wonderful experience working with Shabana Seemee at the time of submission and processing of the papers. Shabana was always ready to support us whenever we had either a problem or a query.
We would like to acknowledge the high standard of all others who took care of editing and processing the papers to obtain the best final quality at the time of publication.
We would be delighted to continue to collaborate with the journal.

Dr. Rodolfo Montironi
Has contributed: Editorial Mini-Thematic Issue: Morphological and Molecular Backgrounds for Personalized Therapies in Genitourinary Cancers

Current Drug Targets

,

Volume 16

-

Number 7



Is there a Role for Bevacizumab in Non-Glial Tumors?

; Pp: 684 - 688

Elisa Trevisan, Luca Bertero, Michela Magistrello, Roberta Ruda and Riccardo Soffietti


DOI: 10.2174/1389450116666150325230810
Abstract Purchase Reprints Eprints Rights & Permissions

  
  



Heterocyclic Scaffolds: Centrality in Anticancer Drug Development

; Pp: 711 - 734

Imran Ali, Mohammad Nadeem Lone, Zeid A. Al-Othman, Abdulrahman Al-Warthan and Mohd. Marsin Sanagi


DOI: 10.2174/1389450116666150309115922
Abstract Purchase Reprints Eprints Rights & Permissions

  
  



Statins and epilepsy: preclinical studies, clinical trials and statin-anticonvulsant drug interactions

; Pp: 747 - 756

Francesca Scicchitano, Andrew Constanti, Rita Citraro, Giovambattista De Sarro and Emilio Russo


DOI: 10.2174/1389450116666150330114850
Abstract Purchase Reprints Eprints Rights & Permissions

  
  



Targeting The Noradrenergic System In Posttraumatic Stress Disorder: A Systematic Review And Meta-Analysis Of Prazosin Trials


Domenico De Berardis, Stefano Marini, Nicola Serroni, Felice Iasevoli, Carmine Tomasetti, Andrea de Bartolomeis, Monica Mazza, Daniela Tempesta, Alessandro Valchera, Michele Fornaro, Maurizio Pompili, Gianna Sepede, Federica Vellante, Laura Orsolini, Giovanni Martinotti and Massimo Di Giannantonio


View Abstract Purchase Online

  
  


Pattern Recognition by CD6: a Scavenger-Like Lymphocyte Receptor


Adelaida Sarukhan, Mario Martinez-Florensa, Cristina Escoda-Ferran, Esther Carrasco, Esther Carreras and Francisco Lozano


View Abstract Purchase Online

  
  


Loop Diuretics Strategies in Acute Heart Failure: from Clinical Trials to Practical Application


Alberto Palazzuoli, Gaetano Ruocco, Marco Pellegrini, Matteo Beltrami, Gabriele Del Castillo and Ranuccio Nuti


View Abstract Purchase Online

  
  


AMPK as a New Attractive Therapeutic Target for Disease Prevention: the Role of Dietary Compounds


Massimiliano Gasparrini, Francesca Giampieri, Jose M. Alvarez Suarez, Luca Mazzoni, Tamara Y. Forbes Hernandez, Jose L. Quiles, Pedro Bullon and Maurizio Battino


View Abstract Purchase Online

  
  


Endogenous Cardioprotective Agents: Role in Pre and Postconditioning


C Penna, R Granata, C G Tocchetti, M P Gallo, G Alloatti and P Pagliaro


View Abstract Purchase Online

  
  


Zoledronic Acid: Pleiotropic Anti-Tumor Mechanism and Therapeutic Outlook for Osteosarcoma


Zhengxiao Ouyang, Haowei Li, Zanjing Zhai, Jiake Xu, Crispin R. Dass, An Qin and Kerong Dai


View Abstract Purchase Online

  
  


Impairment of Liver Glycogen Storage in the db/db Animal Model of Type 2 Diabetes: a Potential Target for Future Therapeutics?


Mitchell A. Sullivan, Brooke E. Harcourt, Ping Xu, Josephine M. Forbes and Robert G. Gilbert


View Abstract

  
  


Phospholipase A2 Isoforms as Novel Targets for Prevention and Treatment of Inflammatory and Oncologic Diseases


Nagendra Sastry Yarla, Anupam Bishayee, Lakshmipathi Vadlakonda, Ramakrishna Chintala, Govinda Rao Duddukuri, Pallu Reddanna and D.S.V.G.K. Kaladhar


View Abstract

  
  


HDL as a Target for Glycemic Control


Boris Waldman, Alicia J. Jenkins, David Sullivan, Martin K.C. Ng and Anthony C. Keech


View Abstract

  
  


VIRTUAL SCREENING FOR THE DEVELOPMENT OF DUAL-INHIBITORS TARGETING TOPOISOMERASE IB AND TYROSYL-DNA PHOSPHODIESTERASE 1


Francesca Cardamone, Simone Pizzi, Federico Iacovelli, Mattia Falconi and Alessandro Desideri


View Abstract

  
  


Tapping into mitochondria to find novel targets for diabetes complications


Nicole Flemming, Linda Gallo, Josephine Maree Forbes and Micheal S Ward


View Abstract

  
  


Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events In Diabetic Nephropathy?


Karly C. Sourris, Henry Yao, George Jerums, Mark E. Cooper, Elif I. Ekinci and Melinda T. Coughlan


View Abstract

  
  


Molecular Pathophysiology of Priapism: Emerging Targets

, 2015; 16(5): 474 - 483

Uzoma A. Anele, Belinda F. Morrison and Arthur L. Burnett


DOI: 10.2174/1389450115666141111111842
View Abstract Purchase Online Rights and Permissions

  
  


Molecular Foundations for Personalized Therapy in Prostate Cancer

, 2015; 16(2): 103 - 114

Kurt W. Fisher, Rodolfo Montironi, Antonio Lopez Beltran, Holger Moch, Lisha Wang, Marina Scarpelli, Sean R. Williamson, Michael O. Koch and Liang Cheng


DOI: 10.2174/1389450115666141229154500
View Abstract Purchase Online Rights and Permissions

  
  


Affinity-Based Methods in Drug-Target Discovery

, 2015; 16(1): 60 - 76

Gabriela Rylova, Tomas Ozdian, Lakshman Varanasi, Miroslav Soural, Jan Hlavac, Dusan Holub, Petr Dzubak and Marian Hajduch


DOI: 10.2174/1389450115666141120110323
View Abstract Download Free Rights and Permissions

  
  


Synergistic Activity of the c-Met and Tubulin Inhibitor Tivantinib (ARQ197) with Pemetrexed in Mesothelioma Cells

, 2014; 15(14): 1331 - 1340

Leticia G. Leon, Maria Gemelli, Rocco Sciarrillo, Amir Avan, Niccola Funel and Elisa Giovannetti


DOI: 10.2174/1389450116666141205160924
View Abstract Purchase Online Rights and Permissions

  
  


Targeting SUMOylation Cascade for Diabetes Management

, 2014; 15(12): 1094 - 1106

Dornadula Sireesh, Elango Bhakkiyalakshmi, Kunka Mohanrama Ramkumar, Shanmugakani Rathinakumar, Panneer Selvam Anto Jennifer, Palanisamy Rajaguru and Ramasamy Paulmurugan


DOI: 10.2174/1389450115666140915124747
View Abstract Purchase Online Rights and Permissions

  
  


Advertisement

Related Journals




Related eBooks


Webmaster Contact: urooj@benthamscience.org Copyright © 2015 Bentham Science